Effects of The Cancer Genome Atlas
Effects of The Cancer Genome Atlas
State of CNS germ cell tumour research in North America
Possible consequences and potential for improvement for time of diagnosis for intracranial germ cell tumours
miR 371-373 and miR 302 cluster expression in body fluids as potential biomarkers of malignant germ cell tumours
Time to diagnosis for intracranial germ cell tumours: Possible consequences and potential for improvement
Blood biopsies for tumour cell detection
Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials
Integrating breast cancer genomics and proteomics
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer
Breast cancer heterogeneity no barrier to predictive testing
Single cell sequencing techniques in early and late breast cancer
Measurement variation influences gene expression profiles of breast cancer